Search results
Medicare Part D Plans Poorly Cover Adalimumab Biosimilars
Medscape· 14 hours agoThis narrow coverage limits the cost-saving potential of these biosimilar competitors, expert said.
What to know when enrolling in Medicare after age 65 with health issues
Las Vegas Review-Journal· 2 hours agoThe 2025 Medicare Part D plans will be released Oct. 1. I recommend that you and Sandy begin...
Enrolling in Medicare over 65 with health issues
The Salem News· 3 hours agoThe 2025 Medicare Part D plans will be released on October 1. Scott, I recommend that you and Sandy begin researching which Medicare ...
Medicare Advantage Boom: Soaring Costs & Unclear Quality
TheStreet.com· 3 days agoAs Medicare Advantage enrollment skyrockets, the Medicare Rights Center calls for improved data collection to ensure quality care, fair pricing, and responsible ...
In February, Medicare began negotiating behind closed doors for lower drug prices
NPR· 2 days agoMedicare drug price negotiation is something President Biden brought up last week at a campaign stop in Philadelphia, and will definitely continue talking ...
Biden's Inflation Reduction Act Unravels Medicare Part D
Forbes· 7 days agoIn May, Medicare bureaucrats released new guidance that details how they'll conduct the drug pricing...
Fox’s John Roberts Pushes Back in Spat With Biden Campaign After He Was Accused of a ‘Blatant Lie’
Mediaite· 2 days agoFox News anchor John Roberts responded with receipts to President Joe Biden’s campaign accusing him...
Millions of Americans need drugs like Ozempic: Will it bankrupt the health care system?
Medical Xpress· 6 days ago"As important as these drugs are, they will not do any good for the millions of patients who cannot...
Older Americans hit hard by Biden’s Medicare funny business
The Washington Times· 3 days agoThe federal legislation, signed into law in 2022, flips Medicare Part D upside down by empowering...
JD Supra: Better Health Care Newsletter
JD Supra· 2 hours agoFederal officials have capped the cost of insulin at $35 a month. For now, that gives relief only to patients 65 and older covered by Medicare. Big Pharma in recent years has flouted that charitable intent.